<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220814055691N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-09</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>tele biofeedback and shoulder physiotherapy effectiveness on the quality of life of breast cancer patients with a history of mastectomy</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the therapeutic effectiveness of telebiofeedback and conventional shoulder physiotherapy methods on improving the quality of life of breast cancer patients with a history of mastectomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-09-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65277</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method will be simple, which is done by the random numbers table method
The table of random numbers is a set of numbers without a specific pattern and order, which is determined to read the numbers first, and in this study, even numbers will be telebiofeedback and odd numbers will be physiotherapy.
Due to the fact that the sampling is done in a multi-centered manner, the method of concealment is done centrally, and the participants' entry into the study is done by phone call to the Firuzgar center, Blinding description: Patients were evaluated by a separate researcher who did not participate in the selection and treatment of patients and was blind to the procedure.</study_design>
      <phase>N/A</phase>
      <hc_freetext>breast cancer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group (telebiofeedback) which is a specific type of physiotherapy for the shoulder joint and muscles in which the surface electrodes are placed on the patient's skin in specific areas and record the electrical activity of certain muscles based on the location. Patients are first trained on how to use the device, These people will be given the necessary explanations on how to communicate with the doctor/therapist. For 2 months, 2 sessions per week in the first month and 1 session per week in the second month and each session for 20 minutes underwent shoulder muscle biofeedback therapy to strengthen weakened muscles And the necessary muscle relaxation is based on the initial assessment and established protocols. In these sessions, the doctor/therapist is present online And according to the access to the biofeedback program and the results obtained from it, it controls and reviews the sports. During the sessions, the therapist determines the intensity and frequency of the exercises that the patient should do according to the progress of the patient and the frequent evaluations he performs before, during and after the session. Intervention 2: Control group: In the control group, patients are subjected to conventional shoulder physiotherapy for 2 months, 2 sessions per week in the first month and one session per week in the second month, and each session lasts 20 minutes, based on the mentioned protocols. In the control group, the same patients for 2 months, 2 sessions per week in the first month and one session per week in the second month and each session for 20 minutes under conventional shoulder physiotherapy which includes electrical stimulation methods, infrared rays and ultrasound and training Sports will be included. In both cases, due to the nature of sports, the patient will not be deprived of the minimum necessary measures and will not cause a disturbance in the patient's recovery process.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No additional information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mozhde mogammadpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>behafrin ave. valiasr squer firozgar hospital</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1593748712</zip>
        <telephone>+98 21 8214 1229</telephone>
        <email>mozhde.mohammadpour73@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>bijan forough</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>behafrin ave.valiasr square firozgar hospital</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1593748711</zip>
        <telephone>+98 21 8214 1229</telephone>
        <email>bforough@tums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women over 18 and under 65 years old with breast cancer who have undergone radical mastectomy modification.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>metastatic cancer
pregnancy
history of trauma to neck and upper limb
cognition impairment
radiation
leaving Tehran
Death
reluctance to intervention
any previous dysfunction in shoulder function</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>D05</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Carcinoma in situ of breast</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group (telebiofeedback) which is a specific type of physiotherapy for the shoulder joint and muscles in which the surface electrodes are placed on the patient's skin in specific areas and record the electrical activity of certain muscles based on the location. Patients are first trained on how to use the device, These people will be given the necessary explanations on how to communicate with the doctor/therapist. For 2 months, 2 sessions per week in the first month and 1 session per week in the second month and each session for 20 minutes underwent shoulder muscle biofeedback therapy to strengthen weakened muscles And the necessary muscle relaxation is based on the initial assessment and established protocols. In these sessions, the doctor/therapist is present online And according to the access to the biofeedback program and the results obtained from it, it controls and reviews the sports. During the sessions, the therapist determines the intensity and frequency of the exercises that the patient should do according to the progress of the patient and the frequent evaluations he performs before, during and after the session.</i_keyword>
      <i_keyword>Control group: In the control group, patients are subjected to conventional shoulder physiotherapy for 2 months, 2 sessions per week in the first month and one session per week in the second month, and each session lasts 20 minutes, based on the mentioned protocols. In the control group, the same patients for 2 months, 2 sessions per week in the first month and one session per week in the second month and each session for 20 minutes under conventional shoulder physiotherapy which includes electrical stimulation methods, infrared rays and ultrasound and training Sports will be included. In both cases, due to the nature of sports, the patient will not be deprived of the minimum necessary measures and will not cause a disturbance in the patient's recovery process.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of life in qlqc30 questionnaire. Timepoint: The intervention is measured in weeks 0, 4, and 12 after intervention. Method of measurement: Based on  Quality of Life Questionnaire-Core 30 (QLQC30) questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-06-19</approval_date>
        <contact_name>Research Ethics Committee of Iran University of Medical Sciences.</contact_name>
        <contact_address>Valiasr Square, Beh Afarin Street, Firouzgar Hospital. tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
